annual accounts payable:
$8.88M+$5.73M(+182.06%)Summary
- As of today (June 25, 2025), SLNO annual accounts payable is $8.88 million, with the most recent change of +$5.73 million (+182.06%) on December 31, 2024.
- During the last 3 years, SLNO annual accounts payable has risen by +$5.63 million (+172.96%).
- SLNO annual accounts payable is now at all-time high.
Performance
SLNO Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$5.48M-$3.40M(-38.27%)Summary
- As of today (June 25, 2025), SLNO quarterly accounts payable is $5.48 million, with the most recent change of -$3.40 million (-38.27%) on March 31, 2025.
- Over the past year, SLNO quarterly accounts payable has dropped by -$2.54 million (-31.65%).
- SLNO quarterly accounts payable is now -38.27% below its all-time high of $8.88 million, reached on December 31, 2024.
Performance
SLNO quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SLNO Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +182.1% | -31.6% |
| 3 y3 years | +173.0% | +127.4% |
| 5 y5 years | +345.2% | +57.6% |
SLNO Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +399.8% | -38.3% | +208.6% |
| 5 y | 5-year | at high | +399.8% | -38.3% | +208.6% |
| alltime | all time | at high | >+9999.0% | -38.3% | +9402.6% |
SLNO Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $5.48M(-38.3%) |
| Dec 2024 | $8.88M(+182.1%) | $8.88M(+42.3%) |
| Sep 2024 | - | $6.24M(+68.0%) |
| Jun 2024 | - | $3.72M(-53.7%) |
| Mar 2024 | - | $8.02M(+154.7%) |
| Dec 2023 | $3.15M(+77.2%) | $3.15M(-2.1%) |
| Sep 2023 | - | $3.22M(-6.6%) |
| Jun 2023 | - | $3.44M(+23.9%) |
| Mar 2023 | - | $2.78M(+56.3%) |
| Dec 2022 | $1.78M(-45.4%) | $1.78M(-23.5%) |
| Sep 2022 | - | $2.32M(-3.4%) |
| Jun 2022 | - | $2.41M(-0.2%) |
| Mar 2022 | - | $2.41M(-25.9%) |
| Dec 2021 | $3.25M(-6.7%) | $3.25M(-15.7%) |
| Sep 2021 | - | $3.86M(+15.2%) |
| Jun 2021 | - | $3.35M(-28.3%) |
| Mar 2021 | - | $4.67M(+33.8%) |
| Dec 2020 | $3.49M(+74.9%) | $3.49M(+8.6%) |
| Sep 2020 | - | $3.21M(-12.1%) |
| Jun 2020 | - | $3.66M(+5.1%) |
| Mar 2020 | - | $3.48M(+74.4%) |
| Dec 2019 | $2.00M | $2.00M(+15.0%) |
| Sep 2019 | - | $1.74M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $1.74M(+38.3%) |
| Mar 2019 | - | $1.26M(+34.7%) |
| Dec 2018 | $934.00K(+47.6%) | $934.00K(-25.0%) |
| Sep 2018 | - | $1.25M(+26.9%) |
| Jun 2018 | - | $981.00K(-13.4%) |
| Mar 2018 | - | $1.13M(+79.0%) |
| Dec 2017 | $633.00K(+54.2%) | $633.00K(-1.4%) |
| Sep 2017 | - | $642.00K(-37.6%) |
| Jun 2017 | - | $1.03M(+10.1%) |
| Mar 2017 | - | $935.00K(+127.8%) |
| Dec 2016 | $410.50K(-40.9%) | $410.50K(-52.4%) |
| Sep 2016 | - | $862.00K(-9.9%) |
| Jun 2016 | - | $957.00K(-24.2%) |
| Mar 2016 | - | $1.26M(+81.6%) |
| Dec 2015 | $695.10K(-29.6%) | $695.10K(-27.1%) |
| Sep 2015 | - | $953.00K(-3.6%) |
| Jun 2015 | - | $989.00K(+59.3%) |
| Mar 2015 | - | $621.00K(-37.1%) |
| Dec 2014 | $986.80K(+1610.2%) | $986.80K(-20.3%) |
| Sep 2014 | - | $1.24M(+93.6%) |
| Jun 2014 | - | $639.30K(+619.9%) |
| Mar 2014 | - | $88.80K(+53.9%) |
| Dec 2013 | $57.70K(-73.7%) | $57.70K |
| Dec 2012 | $219.50K | - |
FAQ
- What is Soleno Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Soleno Therapeutics?
- What is Soleno Therapeutics annual accounts payable year-on-year change?
- What is Soleno Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly accounts payable year-on-year change?
What is Soleno Therapeutics annual accounts payable?
The current annual accounts payable of SLNO is $8.88M
What is the all time high annual accounts payable for Soleno Therapeutics?
Soleno Therapeutics all-time high annual accounts payable is $8.88M
What is Soleno Therapeutics annual accounts payable year-on-year change?
Over the past year, SLNO annual accounts payable has changed by +$5.73M (+182.06%)
What is Soleno Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SLNO is $5.48M
What is the all time high quarterly accounts payable for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly accounts payable is $8.88M
What is Soleno Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SLNO quarterly accounts payable has changed by -$2.54M (-31.65%)